Spasmodic Dysphonia Pain

• Status: Recruiting
• Trial end date: 2023-04-01
• Target enrollment: 0
• Participant gender: All

Summary

This study aims to identify adjuvant methods to improve patient comfort during in-office laryngology procedures.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mayo Clinic
• Treatments: Lidocaine

Criteria

Inclusion Criteria:

• Spasmodic dysphonia with or without tremor

• Receiving botox as treatment via a transcricothyroid approach

Exclusion Criteria:

• Allergy to lidocaine